Biomarkers of Helicobacter pylori-associated gastric cancer.

Cara L. Cooke, Javier Torres, Jay V Solnick

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Helicobacter pylori-associated gastric cancer is a major cause of morbidity and mortality worldwide, and is predicted to become even more common in developing countries as the population ages. Since gastric cancer develops slowly over years to decades, and typically progresses though a series of well-defined histologic stages, cancer biomarkers have potential to identify asymptomatic individuals in whom surgery might be curative, or even those for whom antibiotics to eradicate H. pylori could prevent neoplastic transformation. Here we describe some of the challenges of biomarker discovery, summarize current approaches to biomarkers of gastric cancer, and explore some recent novel strategies.

Original languageEnglish (US)
Pages (from-to)532-540
Number of pages9
JournalGut Microbes
Issue number6
StatePublished - 2013

ASJC Scopus subject areas

  • Gastroenterology
  • Infectious Diseases
  • Microbiology (medical)
  • Microbiology


Dive into the research topics of 'Biomarkers of Helicobacter pylori-associated gastric cancer.'. Together they form a unique fingerprint.

Cite this